Protein and metal analysis core
蛋白质和金属分析核心
基本信息
- 批准号:8452706
- 负责人:
- 金额:$ 17.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-08-11 至
- 项目状态:未结题
- 来源:
- 关键词:AdultAmyotrophic Lateral SclerosisCell LineCellsChemicalsChromatographyCoupledCuprozinc Superoxide DismutaseDataDeuteriumEnzymesEventFamilyFluorescence MicroscopyFourier TransformHeterogeneityHumanHydrogenHydroxyl RadicalImageIn VitroInstructionKineticsLaboratoriesLeadLifeLinkMass Spectrum AnalysisMeasurementMeasuresMetalsMolecularMolecular ConformationMolecular Sieve ChromatographyMonitorMotor NeuronsMutationNatureOrganellesPathway interactionsPlasmaPreparationProcessPropertyProteinsProteomicsProtocols documentationReactionReproducibilityResolutionRoentgen RaysRouteSamplingServicesSliceSpectroscopy, Fourier Transform InfraredStem cellsStructureSynchrotronsTechniquesTherapeutic InterventionTissuesToxic effectTransgenic AnimalsTransgenic MiceTransgenic OrganismsWorkbasehuman embryonic stem cellinsightmembermutantnoveloxidationprogramsresearch studysuperoxide dismutase 1
项目摘要
PROJECT SUMMARY (See instructions):
The Valentine program project seeks to determine the molecular basis of amyotrophic lateral sclerosis (ALS)
caused by mutations in superoxide dismutase 1 (SODl). Having established that SODl proteins are
amyloidogenic, four Projects propose novel experiments toward luiderstanding the nature of toxicity in ALS.
The analytical core (Core A; PI: Whitelegge) provides services for physical, chemical and proteomic analysis
of SODl-multimers and other extracts from human cells and transgenic arumals.
Specific Aim 1. Metal analysis: Incomplete or improper metallation of SODl has profotind effects upon the
protein's properties and it is therefore critically important that levels of Cu and Zn are measured accurately
in samples important to projects 1, 2, 3 & 4. Inductively coupled plasma mass spectrometry (ICP-MS) as well
as online size-exclusion chromatography ICP-MS will be used to measure metal levels with great sensitivity
and reproducibility in whole tissues, isolated organelles and isolated proteins. Metal concentration,
distribution, and oxidation state will be spatially imaged across tissue slices using synchrotron X-ray
fluorescence microscopy (with Lisa Miller, Brookhaven National Laboratory).
Specific Aim 2. Protein multimer analysis: Non-native forms of SODl including monomeric and multimeric
species appear key to toxicity in FALS. The diversity of structures that SODl can attain under different
conditions, and the factors that influence its kinetics, will be characterized toward understanding the
pathway to toxicity. Core A will use chromatography, mass spectrometry (including hydrogen-deuterium
exchange and hydroxyl radical footprinting), synchrotron FTIR imaging, and other techniques to
characterize the size and structure of multimer preparations and their heterogeneity. Soluble oligomers and
fibrils produced in vitro (Proj. 1 & 4), multimers from human embryoiuc stem cell motor neurons (HESCMNs;
Proj. 2) and transgenic mice (Proj. 3) will be analyzed.
Spedfic Aim 3. General and targeted proteomics: Measurements of protein identity and quantity are
required for work proposed in Projects 1, 2,3 & 4. Mass spectrometry protocols are established for a variety
of measurements. Proteomics will be used to measure early cellular events occurring after HESC-MNs are
exposed to defined SODl preparations (Projects 1 & 2) toward defining the molecular basis of toxicity in
FALS. We will use top-down high-resolution Fourier-transform mass spectrometry experiments and
establish selected reaction monitoring protocols for accurate quantification of WT versus mutant SODl in
mixed expression experiments (Projects 2 & 3).
项目概述(见说明):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julian P Whitelegge其他文献
Julian P Whitelegge的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julian P Whitelegge', 18)}}的其他基金
Organ-specific NRF2-mediated protein signatures of radiation exposure & tissue da
辐射暴露的器官特异性 NRF2 介导的蛋白质特征
- 批准号:
8653935 - 财政年份:2012
- 资助金额:
$ 17.26万 - 项目类别:
Organ-specific NRF2-mediated protein signatures of radiation exposure & tissue da
辐射暴露的器官特异性 NRF2 介导的蛋白质特征
- 批准号:
8469390 - 财政年份:2012
- 资助金额:
$ 17.26万 - 项目类别:
Organ-specific NRF2-mediated protein signatures of radiation exposure & tissue da
辐射暴露的器官特异性 NRF2 介导的蛋白质特征
- 批准号:
8370442 - 财政年份:2012
- 资助金额:
$ 17.26万 - 项目类别:
Proteomic Approaches to Protein Fatty Acylation
蛋白质脂肪酰化的蛋白质组学方法
- 批准号:
7910658 - 财政年份:2009
- 资助金额:
$ 17.26万 - 项目类别:
Subtle Modification of Isotope Ratio Proteomics (SMIRP)
同位素比蛋白质组学的微妙修改 (SMIRP)
- 批准号:
7347308 - 财政年份:2008
- 资助金额:
$ 17.26万 - 项目类别:
Subtle Modification of Isotope Ratio Proteomics (SMIRP)
同位素比蛋白质组学的微妙修改 (SMIRP)
- 批准号:
7770893 - 财政年份:2008
- 资助金额:
$ 17.26万 - 项目类别:
相似海外基金
Amyotrophic Lateral Sclerosis: treating the circuit behind the disease
肌萎缩侧索硬化症:治疗疾病背后的回路
- 批准号:
MR/Y014901/1 - 财政年份:2024
- 资助金额:
$ 17.26万 - 项目类别:
Research Grant
Dysregulation of RNA processing as a driver of motor neuron dysfunction in Amyotrophic Lateral Sclerosis
RNA 加工失调是肌萎缩侧索硬化症运动神经元功能障碍的驱动因素
- 批准号:
MR/Y014286/1 - 财政年份:2024
- 资助金额:
$ 17.26万 - 项目类别:
Research Grant
Fasciculation IN Amyotrophic Lateral Sclerosis Using MUMRI (FINALSUM)
使用 MUMRI 治疗肌萎缩侧索硬化症的肌束颤动 (FINALSUM)
- 批准号:
MR/Y503502/1 - 财政年份:2024
- 资助金额:
$ 17.26万 - 项目类别:
Research Grant
I-Corps: Developing A Blood-Based Biomarker for the Detection and Monitoring of Amyotrophic Lateral Sclerosis
I-Corps:开发一种基于血液的生物标志物,用于检测和监测肌萎缩侧索硬化症
- 批准号:
2317745 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Standard Grant
Development of CM-CS1 CAR Treg to Treat Amyotrophic Lateral Sclerosis (ALS)
开发 CM-CS1 CAR Treg 治疗肌萎缩侧索硬化症 (ALS)
- 批准号:
10696512 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Targeted immunotherapy for amyotrophic lateral sclerosis and frontotemporal dementia
肌萎缩侧索硬化症和额颞叶痴呆的靶向免疫治疗
- 批准号:
10759808 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Metrics for Brain Controlled Communication: A comprehensive review of clinical outcome assessments for communication brain computer interfaces in amyotrophic lateral sclerosis
脑控制通信指标:肌萎缩侧索硬化症通信脑机接口临床结果评估的全面综述
- 批准号:
10848139 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Resolving the Role of Neuronal STING in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
解决神经元 STING 在肌萎缩侧索硬化症和额颞叶痴呆中的作用
- 批准号:
10606865 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
The Gut Microbiota as a Contributor to Sexual Dimorphism in Amyotrophic Lateral Sclerosis
肠道微生物群是肌萎缩侧索硬化症性别二态性的一个促成因素
- 批准号:
488892 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Operating Grants
The biochemical stratification of amyotrophic lateral sclerosis
肌萎缩侧索硬化症的生化分层
- 批准号:
MR/Y001095/1 - 财政年份:2023
- 资助金额:
$ 17.26万 - 项目类别:
Fellowship